MJ

Mark Jacobstein

General Partner at Near Horizon

Stanford, California

Overview 

Mark Jacobstein is a General Partner at Near Horizon in Stanford, California, specializing in building AI-powered startups and investing in various sectors like Generative Tech/AI and Enterprise Applications. With a background in Venture Building and serving as a Co-Founder and President of Jimini Health, he has successfully invested in companies like OurHealthMate and Scoot, showcasing his expertise in fundraising and strategic partnerships in the tech industry.

Work Experience 

  • Co-founder and General Partner

    2023 - Current

    Near Horizon is pioneering a new approach to venture building. We partner with entrepreneurs at company formation to build AI-powered companies, providing both capital and hands-on help

  • Co-Founder and President

    2023

    Jimini’s mission is to radically improve the efficacy of mental health care. We are starting by building an AI-augmented therapy model, where we have redesigned the entire patient journey, creating a clinically effective, more modern treatment for patients. Learn more and sign up at jiminihealth.com As co-founder and President, I work across many aspects of the business, including user experience, corporate strategy, recruiting the senior team and scientific leadership, and GTM.

  • Venture Builder

    2024

    Second automates all of your codebase maintenance, including upgrades (React 18 -> 19, Python 3.10 -> 3.14) and migrations (Angular -> React). We can free your engineering team to spend more time on your product, all for the fraction of the cost of a single engineer. Let's get started today, reach out for more information.

  • Venture Builder

    2023

  • Advisor

    2023

  • Board Member

    2018

Luminopia develops a new class of treatments for significant neuro-visual disorders.

Raised $33,150,000.00 from Broadfin Advisors, U.S. Venture Partners, Shangbay Capital and The Vertical Group.

  • Board Member

    2020

Odin is intended for use on common mobile smartphones.

  • Executive Business Advisor and stay-at-home dad

    2023 - 2023

  • Executive Business Advisor at Immunai

    2022 - 2023

    Part-time business advisor for Immunai and stay-at-home dad.

  • Chief Business Officer

    2020 - 2022

Immunai is a biotech company that provides mapping and reprogramming immunology, machine learning, and software engineering.

Raised $295,000,000.00 from Piedmont Capital Investments, Alexandria Venture Investments, Koch Disruptive Technologies, 8VC, ICon, Meron Capital and Talos VC.

  • Co-Chair Working Group on Data Access

    2019 - 2019

    Co-chair, along with Anish Chopra (ex-CTO of America) of the BCI workgroup on data access.

Education 

Articles About Mark

Relevant Websites